Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

innovation   crawled date : 2021 - 11 - 04    save search

Quotient’s 10th Annual Hack Day Celebrates Employee Innovation
Published: 2021-11-04 (Crawled : 22:00) - quotient.com
QUOT | $3.99 0.0% 1.1M twitter stocktwits trandingview |
Commercial Services
| | O: 1.53% H: 8.54% C: 6.7%


Eledon Pharmaceuticals CEO David-Alexandre C. Gros, M.D., to Present at CareDx Virtual Transplant Innovation Day during ASN Kidney Week 2021
Published: 2021-11-04 (Crawled : 22:00) - globenewswire.com
ELDN | $1.99 180K twitter stocktwits trandingview |
Manufacturing
| | O: 0.0% H: 0.0% C: -1.58%
CDNA | $8.17 1.24% 37K twitter stocktwits trandingview |
Health Technology
| | O: 2.22% H: 2.01% C: -4.39%

ceo kidney
BankProv Chosen by Capchase to Launch Innovative Product for Growing Startups
Published: 2021-11-04 (Crawled : 17:00) - bankprov.com
FRBA | News | $12.2 0.66% 13K twitter stocktwits trandingview |
Finance
| | O: -3.13% H: 0.0% C: 0.0%

growing
EZGO Launches New Brand with the Release of Seven Independent Innovation Product Models
Published: 2021-11-04 (Crawled : 13:00) - prnewswire.com
EZGO | $1.885 -0.79% 67K twitter stocktwits trandingview |
| | O: 2.6% H: 0.0% C: -1.69%


The SynBio Innovation Accelerator, a Collaboration between Codexis and Casdin Capital, Enables $10 million Investment in Molecular Assemblies, Inc.
Published: 2021-11-04 (Crawled : 13:00) - biospace.com/
CDXS | News | $2.79 -0.36% 32K twitter stocktwits trandingview |
Process Industries
| | O: 0.71% H: 0.0% C: 0.0%

collaboration molecular
2seventy bio Completes Spin Transaction and Launches Innovative Immuno-oncology Cell Therapy Company
Published: 2021-11-04 (Crawled : 12:00) - biospace.com/
JNJ | News | $146.315 0.4% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.13% H: 0.0% C: 0.0%
BLUE | $0.9618 0.92% 800K twitter stocktwits trandingview |
Health Technology
| | O: 0.24% H: 0.0% C: 0.0%

therapy
Innovent Announces NMPA Acceptance of a Supplemental New Drug Application for Sintilimab in Combination with Chemotherapy as First-Line Treatment for Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
Published: 2021-11-04 (Crawled : 09:00) - prnewswire.com
LLY | $745.04 -0.12% 410K twitter stocktwits trandingview |
Health Technology
| | O: 3.16% H: 0.0% C: 0.0%
INCY | $52.755 -0.12% 150K twitter stocktwits trandingview |
Health Technology
| | O: 2.41% H: 0.0% C: 0.0%

new drug treatment application therapy drug
Gainers vs Losers
84% 16%

Top 10 Gainers
AGBA | News | $1.37 242.5% 76M twitter stocktwits trandingview |
Finance

EGOX | $0.0835 131.94% 160M twitter stocktwits trandingview |

ZCMD | $2.18 50.35% 24M twitter stocktwits trandingview |
Commercial Services

CHRO | $1.73 41.22% 46K twitter stocktwits trandingview |
n/a

RWOD | $10.61 32.68% 5.1M twitter stocktwits trandingview |
n/a

NVFY | $2.77 31.28% 2.2M twitter stocktwits trandingview |
Consumer Durables

AULT | $0.3174 31.1% 28M twitter stocktwits trandingview |
Manufacturing

WISA 4 | $7.11 20.71% 4.7M twitter stocktwits trandingview |
Electronic Technology

LIFW | News | $0.99 19.26% 800K twitter stocktwits trandingview |
Administrative and Support and ...

PRTG | $0.285 18.75% 140K twitter stocktwits trandingview |
Mining, Quarrying, and Oil and ...


Your saved searches
Save your searches and get alerts when important news are released.